Investment Opportunity

AngioSoma (OTCBB: SOAN) prides itself on our technology, patents, team and potential medical breakthroughs. Below please find our May 2021 Investment Slide Deck for review.
Please contact with any questions.
Thank you.


AngioSoma, Inc. is a publicly traded clinical stage biotechnology company with the OTCBB ticker symbol SOAN. The company has a patented formulation of currently available drugs which have been shown, in our formulation, to enhance the quality of life for Multiple Sclerosis patients.

AngioSoma does not provide forward-looking information and will consistently update our website as appropriate. If you would like to reach out to our investor relations department, please contact us below or email

Investor Relations Contact


Transfer Agent
Standard Registrar and Transfer Company
440 East 400 South, Suite 200
Salt Lake City, UT 84111
Phone: 801-571-8844 or 801-596-2150
Legal Counsel
Sonfield & Sonfield, Attorneys at Law (information on OTC Markets)
2500 Wilcrest Drive, Suite 300, Houston, TX 77042
M&K CPAS, PLLC (information on OTC Markets)
4100 North Sam Houston Pkwy W, Suite 200-B, Houston, TX 77086
(832) 242-9950